Clinical Trials · NCT05456854
Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp
- Phase
- Phase 1
- Recruitment status
- Withdrawn
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 0
- Start date
- Jun 2022
- Locations
- 1 site, United States
- Primary endpoint
- First Phase Insulin Secretion